Search results for "Linum"

showing 10 items of 103 documents

Oral health effects of botulinum toxin treatment for drooling:a systematic review

2020

Background Drooling is a major morbidity in several neurological diseases. Intraglandular botulinum neurotoxin (BoNT) injections have been used to manage this condition. However, by decreasing salivary flow, BoNT injections may result in an increased risk of caries and other oral adverse effects. In this study, we aimed to assess whether, in patients with drooling, intraglandular BoNT injections are associated with increased dental caries development, modifications on salivary composition (oral pH, buffering capacity and osmolality) and cariogenic bacterial load. Material and Methods We performed a systematic review, searching PubMed, CENTRAL, Web of Science, and Scopus for all experimental…

medicine.medical_specialtyMEDLINEOral HealthReviewOral healthDental CariesDroolinglaw.inventionameloblastomaRandomized controlled triallawInternal medicinemedicineHumansBotulinum Toxins Type AAdverse effectGeneral DentistryUNESCO:CIENCIAS MÉDICASbusiness.industryCerebral Palsyodontogenic tumorSialorrheaMedically compromised patients in Dentistryameloblastoma recurrenceBotulinum toxinOtorhinolaryngologyNeuromuscular AgentsSurgeryObservational studymedicine.symptombusinessoral pathologyBiomedical sciencesmedicine.drug
researchProduct

Botulinum toxin for the treatment of somatic tinnitus

2007

Subjective tinnitus is an auditory sensation experienced in the absence of external or internal acoustic stimuli. It causes significant morbidity and can progress to a chronic debilitating condition. Somatic tinnitus is tinnitus that can be modulated by stimulation of the somatic sensory system. It occurs because of interactions between the auditory and the somatosensory system that may occur at several levels of the central nervous system. In the present chapter, we discuss how botulinum toxin can improve tinnitus and discuss the mechanism of its action, and how it relates to its effects on chronic pain.

medicine.medical_specialtyMechanism (biology)business.industryfungiCentral nervous systemChronic painfood and beveragesStimulationAudiologymedicine.diseaseSomatosensory systemBotulinum toxinmedicine.anatomical_structureSensationotorhinolaryngologic diseasesmedicinemedicine.symptombusinessNeuroscienceTinnitusmedicine.drug
researchProduct

Therapeutic considerations in cerebellopontine angle lipomas inducing hemifacial spasm.

2000

Lipoma is a very rare tumour at the cerebellopontine angle. We report a case of incomplete hemifacial spasm, associated with a lipoma involving and compressing both facial and acoustic nerves at their origin in the brainstem. The patient was treated with medical therapy (botulinum toxin A) and surgery. We present a review of the last ten years of the literature, with particular regard to management.

medicine.medical_specialtyNeurologyDermatologyCerebellopontine Angleotorhinolaryngologic diseasesMedicineHumansHemifacial SpasmBotulinum Toxins Type ACerebellar NeoplasmsNeuroradiologymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral MedicineLipomaMiddle Agedmedicine.diseaseCerebellopontine angleBotulinum toxinMagnetic Resonance ImagingSurgerybody regionsstomatognathic diseasesPsychiatry and Mental healthTreatment OutcomeNeuromuscular AgentsFemaleNeurology (clinical)NeurosurgeryLipomabusinessmedicine.drugHemifacial spasmNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

New strategies for medical management of overactive bladder in children.

2011

Purpose of review The medical treatment of children with non-neurogenic overactive bladder syndrome (OAB) is still limited to a small number of drugs approved for use in childhood according to the national regulations of each country. Recent findings Over the last few years, there were several studies on the use of antimuscarinics other than oxybutynin in children, as well as some on the use of extended release oxybutynin and tolterodine and transdermal oxybutynin. It was shown that the combination of two different anticholinergics might be a well tolerated and successful option in children with OAB refractory to monotherapy, as well as administration of a receptor-selective antimuscarinic …

medicine.medical_specialtyQuinuclidinesBotulinum ToxinsCombination therapyTolterodine TartrateNortropanesUrologyPhenylpropanolamineUrologyUrinationMuscarinic AntagonistsBenzilatesCresolsTetrahydroisoquinolinesmedicineHumansBenzhydryl CompoundsOxybutyninIntensive care medicineChildSolifenacinbusiness.industryUrinary Bladder OveractiveStandard treatmentSolifenacin Succinatemedicine.diseaseBotulinum toxinReceptors MuscarinicOveractive bladderMandelic AcidsPropiverineTolterodinebusinessmedicine.drugCurrent opinion in urology
researchProduct

Hyperhidrosis

2009

Sweating is a physiological and vital process. The basic distinction is made between two types of sweating: thermoregulatory and emotional sweating. Most of the sweat glands are of the eccrine type. They produce a thin secretion that is hypotonic to plasma (e1). Eccrine sweat glands are distributed all over the body; their highest density is in the axillary region, on the palms of the hands, and on the soles of the feet (1). Their main function is thermoregulation. Apocrine sweat glands are found primarily in the axillae and the urogenital region. These scent glands become active during puberty and secrete a viscous fluid. They are responsible for a person’s "personal," occasionally unpleas…

medicine.medical_specialtyScent glandApocrine sweatintegumentary systemHyperhidrosisbusiness.industryPhysiologyGeneral MedicineThermoregulationBotulinum toxinSWEATHydrosisEndocrinologyInternal medicinemedicinemedicine.symptombusinessHomeostasismedicine.drugDeutsches Ärzteblatt international
researchProduct

Efficacy of botulinum toxin in the treatment of bruxism : systematic review

2019

Background Currently it has been shown that botulinum toxin is effective for a wide variety of medical conditions, and can be applied for therapeutic purposes as cosmetic. In recent years, there has been a growing trend in the use of this drug substance to control the muscular overactivity of bruxism. The objective of this study was the use of botulinum toxin type A (BTX-A) than traditional methods, by conducting a systematic review of randomized clinical trials (RCTs) published in the health sciences literature. Material and Methods An electronic search was made in the databases of the PubMed, Cochrane Library and Scopus data between March and October 2017, ECA, which will analyze the effe…

medicine.medical_specialtyToxina botulínicaMEDLINEReviewCochrane LibraryPlaceboInjections Intramuscularlaw.inventionMasseter muscleOcclusal Splints03 medical and health sciences0302 clinical medicineRandomized controlled triallawBotulinum toxinmedicineHumansBotulinum Toxins Type AGeneral DentistryOral Medicine and Pathologybusiness.industryMasseter MuscleBruxisme030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Botulinum toxinstomatognathic diseasesOtorhinolaryngologyNeuromuscular AgentsUNESCO::CIENCIAS MÉDICASPhysical therapySurgeryBruxismbusinessBiomedical sciencesmedicine.drug
researchProduct

Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study.

2021

BACKGROUND Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy. AIM To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone. METHODS We conducted a case-control study involving 30 male patients affected by CAF with hypertonic …

medicine.medical_specialtybusiness.industryChronic anal fissureCase-control studyGeneral MedicineCase Control StudyAnoplastyBotulinum toxinSurgeryFissurectomyBotulinum toxinAnal fissure; Anoplasty; Botulinum toxin; Fissurectomy; ProctologymedicineTonicityProctologyAnal fissurebusinessmedicine.drugWorld journal of clinical cases
researchProduct

Preoperative Botulinum Toxin and Progressive Pneumoperitoneum in Loss of Domain Hernias-Our First 100 Cases

2020

Objectives: Preoperative botulinum toxin type A (BT) and progressive pneumoperitoneum (PPP) are useful tools in the preparation of patients with loss of domain hernias (LODH). The purpose of our retrospective study is to report our experience in the treatment of 100 consecutive patients with LODH, with the combined use of these techniques. Methods: Of the 753 patients operated on for ventral incisional hernia between June 2010 and December 2018 in our hospital, 100 patients with LODH were analyzed retrospectively. Diameters of abdominal cavity and hernia sac, and volumes of incisional hernia (VIH) and abdominal cavity (VAC) were calculated from CT scan, based on the index of Tanaka. Results…

medicine.medical_specialtyincisional herniapreoperative progressive pneumoperitoneumIncisional herniaCombined uselcsh:SurgeryAbdominal cavity03 medical and health sciences0302 clinical medicinePneumoperitoneumMedicineHerniaTransversus abdominisbotulinum toxinOriginal Researchlarge incisional herniabusiness.industryventral herniaRetrospective cohort studylcsh:RD1-811medicine.diseaseBotulinum toxinSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisSurgerybusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials

2023

The purpose of the present paper was to review the available evidence on intra-articular botulinum toxin (BTX) injection in the treatment of knee osteoarthritis and to compare it to other conservative treatment options. A systematic review of the literature was performed on the PubMed, Scopus, Cochrane Library, Web of Science, Pedro and Research Gate databases with the following inclusion criteria: (1) randomized controlled trials (RCTs), (2) written in the English language, and (3) published on indexed journals in the last 20 years (2001–2021) dealing with the use of BTX intra-articular injection for the treatment of knee OA. The risk of bias was assessed using the Cochrane Risk of Bias to…

musculoskeletalSettore MED/34 - Medicina Fisica E RiabilitativaOrganic Chemistryintra-articularGeneral MedicineCatalysisComputer Science ApplicationsarthritiInorganic Chemistrysystematic reviewbotulinumtendinopathyPhysical and Theoretical ChemistryMolecular BiologySpectroscopyInternational Journal of Molecular Sciences
researchProduct

OnabotulinumtoxinA Modulates Visual Cortical Excitability in Chronic Migraine: Effects of 12-Week Treatment

2022

Chronic migraine is a burdensome disease presenting with episodic pain and several symptoms that may persist even among headache attacks. Multisensory integration is modified in migraine, as assessed by the level of the perception of sound-induced flash illusions, a simple paradigm reflecting changes in cortical excitability which reveals to be altered in migraineurs. OnabotulinumtoxinA is an effective preventive therapy for chronic migraineurs, reducing peripheral and central sensitization, and may influence cortical excitability. Patients affected by chronic migraine who started onabotulinumtoxinA preventive therapy were included. Clinical effects (headache diaries and migraine related qu…

onabotulinumtoxinAHealth Toxicology and Mutagenesismultisensory integrationSettore MED/26 - NeurologiaonabotulinumtoxinA; chronic migraine; multisensory integration; visual cortical excitability; neurophysiologychronic migraineneurophysiologyToxicologyvisual cortical excitability
researchProduct